SequelSEC

Adagio Medical Holdings, Inc. ADGM

Surgical & Medical Instruments & Apparatus · CIK 0002006986 · Fiscal year ends 1231

Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$19.82M
Fiscal year ended 2026-06-30
Free cash flow
-$16.57M
Fiscal year ended 2026-06-30

Adagio Medical Holdings, Inc. (ADGM) reported revenue of $0 and net income of -$27.14M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Adagio Medical Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Adagio Medical Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$19.82M
Net income-$27.14M
Research & development$10.20M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$9.53M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Adagio Medical Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$7.74M
Total assets$33.88M
Current assets$10.69M
Total liabilities$34.30M
Current liabilities$7.56M
Total equity incl. NCI-$415.00K
Temporary (mezzanine) equityUnavailable
Inventory$1.99M
Accounts receivableUnavailable
Goodwill$13.97M
Long-term debt$24.84M
Accounts payable$699.00K

Cash flow

Adagio Medical Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$16.53M
Capital expenditures$37.00K
Investing cash flow-$37.00K
Financing cash flowUnavailable
Net change in cash-$460.00K
Stock-based compensation$1.90M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$839.00K

Derived

Adagio Medical Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$16.57M
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio1.41x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ADGM in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-K · Filed 2026-03-27View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.